AIMS: To characterize e-cigarette use, users and effects in a sample of Electronic Cigarette Company (TECC) and Totally Wicked E-Liquid (TWEL) users. DESIGN AND SETTING: Online survey hosted at the University of East London with links from TECC/TWEL websites from September 2011 to May 2012. MEASUREMENTS: Online questionnaire. PARTICIPANTS: One thousand three hundred and forty-seven respondents from 33 countries (72% European), mean age 43 years, 70% male, 96% Causasian, 44% educated to degree level or above. FINDINGS: Seventy-four percent of participants reported not smoking for at least a few weeks since using the e-cigarette and 70% reported reduced urge to smoke. Seventy-two percent of participants used a 'tank' system, most commonly, the eGo-C (23%). Mean duration of use was 10 months. Only 1% reported exclusive use of non-nicotine (0 mg) containing liquid. E-cigarettes were generally considered to be satisfying to use; elicit few side effects; be healthier than smoking; improve cough/breathing; and be associated with low levels of craving. Among ex-smokers, 'time to first vape' was significantly longer than 'time to first cigarette' (t1104 = 11.16, P < 0.001) suggesting a lower level of dependence to e-cigarettes. Ex-smokers reported significantly greater reduction in craving than current smokers (χ(2) 1 = 133.66, P < 0.0007) although few other differences emerged between these groups. Compared with males, females opted more for chocolate/sweet flavours (χ(2) 1 = 16.16, P < 0.001) and liked the e-cigarette because it resembles a cigarette (χ(2) 3 = 42.65, P < 0.001). CONCLUSIONS: E-cigarettes are used primarily for smoking cessation, but for a longer duration than nicotine replacement therapy, and users believe them to be safer than smoking.
AIMS: To characterize e-cigarette use, users and effects in a sample of Electronic Cigarette Company (TECC) and Totally Wicked E-Liquid (TWEL) users. DESIGN AND SETTING: Online survey hosted at the University of East London with links from TECC/TWEL websites from September 2011 to May 2012. MEASUREMENTS: Online questionnaire. PARTICIPANTS: One thousand three hundred and forty-seven respondents from 33 countries (72% European), mean age 43 years, 70% male, 96% Causasian, 44% educated to degree level or above. FINDINGS: Seventy-four percent of participants reported not smoking for at least a few weeks since using the e-cigarette and 70% reported reduced urge to smoke. Seventy-two percent of participants used a 'tank' system, most commonly, the eGo-C (23%). Mean duration of use was 10 months. Only 1% reported exclusive use of non-nicotine (0 mg) containing liquid. E-cigarettes were generally considered to be satisfying to use; elicit few side effects; be healthier than smoking; improve cough/breathing; and be associated with low levels of craving. Among ex-smokers, 'time to first vape' was significantly longer than 'time to first cigarette' (t1104 = 11.16, P < 0.001) suggesting a lower level of dependence to e-cigarettes. Ex-smokers reported significantly greater reduction in craving than current smokers (χ(2) 1 = 133.66, P < 0.0007) although few other differences emerged between these groups. Compared with males, females opted more for chocolate/sweet flavours (χ(2) 1 = 16.16, P < 0.001) and liked the e-cigarette because it resembles a cigarette (χ(2) 3 = 42.65, P < 0.001). CONCLUSIONS: E-cigarettes are used primarily for smoking cessation, but for a longer duration than nicotine replacement therapy, and users believe them to be safer than smoking.
Authors: Ahmad Husari; Alan Shihadeh; Soha Talih; Yasmine Hashem; Marwan El Sabban; Ghazi Zaatari Journal: Nicotine Tob Res Date: 2015-08-13 Impact factor: 4.244
Authors: Bárbara Piñeiro; John B Correa; Vani N Simmons; Paul T Harrell; Nicole S Menzie; Marina Unrod; Lauren R Meltzer; Thomas H Brandon Journal: Addict Behav Date: 2015-09-14 Impact factor: 3.913
Authors: Ann McNeill; Pete Driezen; Sara C Hitchman; K Michael Cummings; Geoffrey T Fong; Ron Borland Journal: Addiction Date: 2019-08-15 Impact factor: 6.526
Authors: Vivian Y Lin; Matthew D Fain; Patricia L Jackson; Taylor F Berryhill; Landon S Wilson; Marina Mazur; Stephen J Barnes; J Edwin Blalock; S Vamsee Raju; Steven M Rowe Journal: Am J Respir Cell Mol Biol Date: 2019-08 Impact factor: 6.914
Authors: Timothy W Lefever; Youn O K Lee; Alexander L Kovach; Melanie A R Silinski; Julie A Marusich; Brian F Thomas; Jenny L Wiley Journal: Drug Alcohol Depend Date: 2017-01-18 Impact factor: 4.492
Authors: Su Hyun Park; Dustin T Duncan; Omar El Shahawy; Lily Lee; Jenni A Shearston; Kosuke Tamura; Scott E Sherman; Michael Weitzman Journal: Am J Prev Med Date: 2017-08-29 Impact factor: 5.043